Home

Legare Meglio cowboy chinese clinical oncology impact factor arco esso partire

Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 -  Clarivate
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 - Clarivate

Evaluating eligibility criteria of oncology trials using real-world data  and AI | Nature
Evaluating eligibility criteria of oncology trials using real-world data and AI | Nature

Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library

Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library

Chinese Journal of Clinical Oncology
Chinese Journal of Clinical Oncology

Frontiers | In Real Life, Low-Level HER2 Expression May Be Associated With  Better Outcome in HER2-Negative Breast Cancer: A Study of the National  Cancer Center, China | Oncology
Frontiers | In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China | Oncology

Clinical course and risk factors for mortality of adult inpatients with  COVID-19 in Wuhan, China: a retrospective cohort study - The Lancet
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study - The Lancet

The dawn of China biopharma innovation | McKinsey
The dawn of China biopharma innovation | McKinsey

Peer-reviewed Oncology & Cancer Research Journal | Oncotarget
Peer-reviewed Oncology & Cancer Research Journal | Oncotarget

Home - Chinese Journal of Cancer Research
Home - Chinese Journal of Cancer Research

Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library

The dawn of China biopharma innovation | McKinsey
The dawn of China biopharma innovation | McKinsey

Cancer drug development in China: recent advances and future challenges -  ScienceDirect
Cancer drug development in China: recent advances and future challenges - ScienceDirect

Journal of Clinical Oncology - Impact Factor, Overall Ranking, Rating,  h-index, Call For Paper, Publisher, ISSN, Scientific Journal Ranking (SJR),  Abbreviation, other Important Details | Resurchify
Journal of Clinical Oncology - Impact Factor, Overall Ranking, Rating, h-index, Call For Paper, Publisher, ISSN, Scientific Journal Ranking (SJR), Abbreviation, other Important Details | Resurchify

China at the threshold | Nature Biotechnology
China at the threshold | Nature Biotechnology

Home - Chinese Clinical Oncology
Home - Chinese Clinical Oncology

Chinese Society of Clinical Oncology|CSCO
Chinese Society of Clinical Oncology|CSCO

Home - Chinese Clinical Oncology
Home - Chinese Clinical Oncology

About Annals of Oncology Impact factor: 32.976
About Annals of Oncology Impact factor: 32.976

Characterization of the genomic landscape and actionable mutations in  Chinese breast cancers by clinical sequencing | Nature Communications
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing | Nature Communications

Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library

Chinese Medicine in Cancer Treatment – How is it Practised in the East and  the West? - Clinical Oncology
Chinese Medicine in Cancer Treatment – How is it Practised in the East and the West? - Clinical Oncology

Chinese Society of Clinical Oncology|CSCO
Chinese Society of Clinical Oncology|CSCO

Chinese Clinical Oncology
Chinese Clinical Oncology

State of Cancer Research Around the Globe
State of Cancer Research Around the Globe

Cancer drug development in China: recent advances and future challenges -  ScienceDirect
Cancer drug development in China: recent advances and future challenges - ScienceDirect